0001193125-23-008334.txt : 20230214 0001193125-23-008334.hdr.sgml : 20230214 20230113160200 ACCESSION NUMBER: 0001193125-23-008334 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioAtla, Inc. CENTRAL INDEX KEY: 0001826892 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851922320 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-0708 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 CORRESP 1 filename1.htm CORRESP

LOGO

11085 Torreyana Road

San Diego, CA 92121

January 13, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

Arzhang Navai, Office of Life Sciences

 

Re:   

BioAtla, Inc.

Registration Statement on Form S-3

Filed January 6, 2023

File No. 333-269148

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Acceleration Request

 

Requested Date:    January 17, 2023
Requested Time:    4:00 p.m. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-269148) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.

The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.

[Signature page follows]


Sincerely,
BIOATLA, INC.
By:  

/s/ Richard Waldron

  Name: Richard Waldron
  Title:   Chief Financial Officer

 

cc:

Chris Vasquez, BioAtla, Inc.

Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP

GRAPHIC 2 g416654g0114010304431.jpg GRAPHIC begin 644 g416654g0114010304431.jpg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end